Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

10 top drug launch disasters
Fierce Pharma
Wed, 11/28/12 - 11:13 am
Tags:
drug launches, Rare Disease Therapeutics, Anascorp, AstraZeneca, Brilinta, Somaxon, Silenor, Sanofi, Multaq, Savient, Krystexxa, XenoPort, Horizant, Human Genome Sciences, Benlysta, Zaltrap, Dendreon, Provenge, KV Pharmaceutical, Makena
AstraZeneca, Pfizer partner on $100M drug research collaboration project
Fierce Biotech
Tue, 11/27/12 - 01:29 pm
Tags:
R&D, Pfizer, AstraZeneca
Investing in a better flu shot
Markewatch
Tue, 11/27/12 - 10:29 am
Tags:
vaccines, Flu, GSK, AstraZeneca, Sanofi
6 Pharmaceutical Stocks to Sell Now
InvestorPlace
Sat, 11/24/12 - 12:24 pm
Tags:
AstraZeneca, Depomed, Avanir, GSK, Pain Therapeutics, Ampio Pharmaceuticals
3 Things to Watch With Nektar Therapeutics
Motley Fool
Mon, 11/19/12 - 01:55 pm
Tags:
Nektar, Naloxegol, AstraZeneca
Teva, AstraZeneca reportedly competing to court Irish drug company Amarin
Philadelphia Inquirer
Sat, 11/17/12 - 02:50 pm
Tags:
Vascepa, Teva Pharmaceuticals, AstraZeneca, Amarin, M&A
This Week in Biotech: Part 2
Motley Fool
Sat, 11/17/12 - 01:49 pm
Tags:
Clovis Oncology, Eli Lilly, Celgene, Nektar, AstraZeneca, Salix, Progenics Pharmaceuticals, Dynavax Technologies, Tranzyme
AstraZeneca's Forxiga For Type 2 Diabetes Is A Potential Blockbuster
Seeking Alpha
Fri, 11/16/12 - 10:13 am
Tags:
AstraZeneca, Forxiga, diabetes, Dapagliflozin
Teva Is Still Healthier Than Its Big Pharma Peers
Seeking Alpha
Thu, 11/15/12 - 10:47 am
Tags:
Teva, AstraZeneca, Bristol-Myers Squibb, GSK, JNJ, Merck, Novo Nordisk, Novartis, Pfizer, Sanofi
Bristol-Myers, AstraZeneca Type 2 diabetes pill gets first major approval, in European Union
Yahoo/AP
Thu, 11/15/12 - 10:46 am
Tags:
diabetes, Bristol-Myers Squibb, AstraZeneca, Europe, SGLT2 inhibitor, Forxiga
Who Will Pioneer the New Diabetes Market?
Motley Fool
Thu, 11/15/12 - 10:45 am
Tags:
diabetes, JNJ, Merck, Bristol-Myers Squibb, AstraZeneca, SGLT2 inhibitor
3 Potential Partners for Amarin
Motley Fool
Thu, 11/15/12 - 10:43 am
Tags:
M&A, Amarin, AstraZeneca, Merck, Eli Lilly
Why Nektar Therapeutics' Shares Tumbled
Motley Fool
Tue, 11/13/12 - 12:09 pm
Tags:
Nektar, AstraZeneca, Naloxegol
Foundation Medicine, AstraZeneca ink cancer genomics pact
Fierce Biotech
Mon, 11/12/12 - 12:32 pm
Tags:
Foundation Medicine, AstraZeneca, genomics
CVS shucking more drugs from its coverage list
Fierce Pharma
Fri, 11/9/12 - 11:26 am
Tags:
CVS, pharmacy benefits, Allergan, Lumigan, Androgel, Abbott Labs, Pfizer, Genotropin, Bristol-Myers Squibb, AstraZeneca, Onglyza
Amarin Still Playing the Dating Game
Motley Fool
Fri, 11/9/12 - 09:50 am
Tags:
Amarin, M&A, AstraZeneca
AstraZeneca, PTSD And A Buried Seroquel Study
Pharmalot
Thu, 11/8/12 - 10:54 am
Tags:
PTSD, AstraZeneca, Seroquel
5 Companies Dominating Diabetes
Motley Fool
Tue, 11/6/12 - 04:21 pm
Tags:
diabetes, AstraZeneca, Bristol-Myers Squibb, Sanofi, Novo Nordisk, MannKind
How Does The Patent Exclusivity Factor Affect The 3 Top Dividend-Paying Healthcare Companies?
Seeking Alpha
Fri, 11/2/12 - 10:26 am
Tags:
patents, Amarin, AstraZeneca, Bristol-Myers Squibb, GSK
Failed AstraZeneca Drugs Seen Holding Key to Next Viagra
Bloomberg
Wed, 10/31/12 - 10:05 am
Tags:
Viagra, AstraZeneca, UK, Medical Research Council

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.